0000950123-18-007503.txt : 20180807 0000950123-18-007503.hdr.sgml : 20180807 20180807160613 ACCESSION NUMBER: 0000950123-18-007503 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180807 DATE AS OF CHANGE: 20180807 EFFECTIVENESS DATE: 20180807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRV GP II, LLC CENTRAL INDEX KEY: 0001614073 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18419 FILM NUMBER: 18997969 BUSINESS ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001614073 XXXXXXXX 06-30-2018 06-30-2018 TRV GP II, LLC
THIRD ROCK VENTURES 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
13F HOLDINGS REPORT 028-18419 N
Kevin Gillis Chief Financial Officer 617-585-2000 /s/ Kevin Gillis Boston MA 08-07-2018 3 4 176369 false 1 028-18439 Mark Levin 2 028-18438 Kevin P. Starr 3 028-18419 Robert I. Tepper
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F SAGE THERAPEUTICS, INC. COM 78667J108 5848 37362 SH DFND 1,2,3 37362 0 0 JOUNCE THERAPEUTICS, INC. COM 481116101 78364 10230349 SH DFND 1,2,3 10230349 0 0 BLUEPRINT MEDICINES CORPORATION COM 09627Y109 55791 878875 SH DFND 1,2,3 878875 0 0 ALLENA PHARMACEUTICALS, INC. COM 018119107 36366 2790964 SH DFND 1,2,3 2790964 0 0